title: Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma.
authors.affiliation: Division of Cancer Treatment, National Cancer Institute, NCI Frederick Cancer.
authors.forename: L A
authors.initials: LA
authors.lastname: VanderMolen
authors.forename: R G
authors.initials: RG
authors.lastname: Steis
authors.forename: P L
authors.initials: PL
authors.lastname: Duffey
authors.forename: K A
authors.initials: KA
authors.lastname: Foon
authors.forename: J W
authors.initials: JW
authors.lastname: Smith
authors.forename: J W
authors.initials: JW
authors.lastname: Clark
authors.forename: K
authors.initials: K
authors.lastname: Conlon
authors.forename: H C
authors.initials: HC
authors.lastname: Stevenson
authors.forename: W J
authors.initials: WJ
authors.lastname: Urba
authors.forename: L C
authors.initials: LC
authors.lastname: Hartmann
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins